Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 96,000 shares, a decrease of 31.3% from the February 13th total of 139,800 shares. Currently, 2.1% of the shares of the company are short sold. Based on an average daily trading volume, of 309,400 shares, the short-interest ratio is presently 0.3 days.
Entero Therapeutics Stock Performance
NASDAQ:ENTO opened at $0.53 on Tuesday. The stock’s 50 day moving average price is $0.53 and its two-hundred day moving average price is $0.52. Entero Therapeutics has a 12-month low of $0.19 and a 12-month high of $3.16.
About Entero Therapeutics
Featured Articles
- Five stocks we like better than Entero Therapeutics
- Investing in Construction Stocks
- Can TikTok Stock Picks Really Make You Rich?
- Airline Stocks – Top Airline Stocks to Buy Now
- The “Quality” Rotation: Back to Basics Investing
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.